This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Scotts Miracle-Gro Begins Exchange of Senior Notes Due 2029
by Zacks Equity Research
The exchange does not mark a new financing transaction and Scotts Miracle-Gro (SMG) will not receive any additional proceeds from the exchange offer.
Scotts Miracle-Gro (SMG) Shares Up 56% in A Year: Here's Why
by Zacks Equity Research
Bright prospects of the Hawthorne business as well as upbeat fiscal 2020 view are contributing to Scotts Miracle-Gro's (SMG) shares.
Are You Looking for a High-Growth Dividend Stock? Scotts Miracle-Gro (SMG) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
Scotts Miracle-Gro (SMG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Scotts Miracle-Gro (SMG) closed the most recent trading day at $101.44, moving -1.67% from the previous trading session.
Why Scotts Miracle-Gro (SMG) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
Why Is Scotts (SMG) Down 1.4% Since Last Earnings Report?
by Zacks Equity Research
Scotts (SMG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Scotts Miracle-Gro (SMG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Scotts Miracle-Gro (SMG) closed at $100.53 in the latest trading session, marking a -1.01% move from the prior day.
Scotts Miracle-Gro Shares Up 11% in 6 Months: Here's Why
by Zacks Equity Research
Upbeat fiscal 2020 outlook and bright prospects of the Hawthorne unit are contributing to the gain in Scotts Miracle-Gro's (SMG) shares.
Why Scotts Miracle-Gro (SMG) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
Scotts Miracle-Gro (SMG) Q4 Earnings Miss, Sales Top Estimates
by Zacks Equity Research
Scotts Miracle-Gro (SMG) witnesses strong growth in the Hawthorne segment in fourth-quarter fiscal 2019, primarily driven by strong demand across the United States.
Why Scotts Miracle-Gro (SMG) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?
by Benjamin Rains
Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?
Scotts Miracle-Gro (SMG) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of -4.60% and 10.45%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
5 Must-See Earnings Charts This Week
by Tracey Ryniec
Wellness and lifestyle companies have been front and center thanks to Millennial demands for experiences. These 5 companies are some of the top names.
Scotts Miracle-Gro to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Sunlight Supply acquisition, higher promotional activities and increased retail support are likely to reflect in Scotts Miracle-Gro's (SMG) Q4 results.
Scotts Miracle-Gro (SMG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Scotts Miracle-Gro (SMG) closed at $98.55 in the latest trading session, marking a -0.1% move from the prior day.
Zacks.com featured highlights include: FTI Consulting, Scotts Miracle-Gro and PennyMac Financial Services
by Zacks Equity Research
Zacks.com featured highlights include: FTI Consulting, Scotts Miracle-Gro and PennyMac Financial Services
Earnings Preview: Scotts Miracle-Gro (SMG) Q4 Earnings Expected to Decline
by Zacks Equity Research
Scotts (SMG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Stocks With Momentum Anomaly to Enhance Portfolio Returns
by Zacks Equity Research
Momentum stocks don't usually offer attractive entry points, as the trend established by these continues for some time. So, any major reversal in trend could offer a solid buying opportunity.
Scotts Miracle-Gro Enters Oversold Territory
by Zacks Equity Research
The Scotts Miracle-Gro has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
B2Gold Concludes Sale of Nicaragua Assets to Calibre Mining
by Zacks Equity Research
B2Gold (BTG) sells its Nicaraguan assets to Calibre Mining and now holds around 30% of Calibre's shares.
Vale Q3 Iron Ore Output Up 35% Q/Q, To Recover 50 Mt by 2021
by Zacks Equity Research
Vale S.A's (VALE) iron ore production numbers in the third quarter exhibit a sequential improvement as mines shut in the wake of the Brumadinho disaster resumed operations.
Here's Why You Should Add Scotts Miracle-Gro (SMG) Stock Now
by Zacks Equity Research
Upbeat view and bright prospects in the Hawthorne unit makes Scotts Miracle-Gro (SMG) an attractive investment option.
Mosaic to Temporarily Curtail Production at Esterhazy Mine
by Zacks Equity Research
Mosaic (MOS) plans to temporarily curb production at its Esterhazy potash mine but assures that this will not hinder development at the Esterhazy mine K3 project.
Fertilizers Industry Outlook: Near-Term Prospects Bleak
by Nilanjan Gupta
Investors may want to consider these fertilizers stocks amid a challenging environment.